Commonwealth Equity Services, LLC Ab Cellera Biologics Inc. Transaction History
Commonwealth Equity Services, LLC
- $77.2 Billion
- Q3 2025
A detailed history of Commonwealth Equity Services, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 15,210 shares of ABCL stock, worth $89,130. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,210
Previous 36,427
58.25%
Holding current value
$89,130
Previous $125,000
38.4%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABCL
# of Institutions
150Shares Held
114MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$161 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$78.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$60.7 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$49.6 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$26.6 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.67B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...